Remogliflozin - GSK 189074

Based on 20 reference(s) in Google Scholar 80 100 20

Axon 1634

CAS [329045-45-6]

MF C23H34N2O7
MW 450.53

  • Purity: 99%
  • Soluble in water and DMSO



Remogliflozin inhibits the sodium-glucose transport (SGLT2) proteins, which are responsible for glucose reabsorption in the kidney. Blocking this transporter causes blood glucose to be eliminated through the urine. Its prodrug is Remoglifozin etabonate (GSK 189075), investigated as a treatment of anti diabetes type II
Size Unit Price Stock
5 mg €150.00 In Stock
25 mg €550.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...